I agree that this site is using cookies. You can find further informations here.
X
Buonerba C
63  results:
Search for persons X
?
1

Progression-free survival as surrogate endpoint in high-ris..:

Marchioni, M. ; Porreca, A. ; Di Nicola, M....
European Urology.  83 (2023)  - p. S401-S402 , 2023
Link: https://doi.org/10.1016/..
 
?
2

Progression-free survival as surrogate endpoint in high-ris..:

Marchioni, M. ; Porreca, A. ; Di Nicola, M....
European Urology Open Science.  44 (2022)  - p. S107 , 2022
Link: https://doi.org/10.1016/..
 
?
3

Impact of Prior Platinum-Based Therapy on Patients Receivin..:

Sonpavde, G. ; Pond, G.R. ; Di Lorenzo, G....
Clinical Genitourinary Cancer.  14 (2016)  6 - p. 494-498 , 2016
Link: https://doi.org/10.1016/..
 
?
4

Neuroendocrine Tumors Diagnosed at the "Antonio Cardarelli"..:

Riccardi, F. ; Nappi, O. ; Balzano, A....
International Journal of Immunopathology and Pharmacology.  24 (2011)  1 - p. 251-256 , 2011
Link: https://doi.org/10.1177/..
 
?
5

Is Hypogammaglobulinemia a Constant Feature in Good's Syndr..:

Federico, P. ; Imbimbo, M. ; Buonerba, C....
International Journal of Immunopathology and Pharmacology.  23 (2010)  4 - p. 1275-1279 , 2010
Link: https://doi.org/10.1177/..
 
?
6

A Long-Lasting Response to Sorafenib Treatment in an Advanc..:

Di Lorenzo, G. ; Imbimbo, M. ; Leopardo, D....
International Journal of Immunopathology and Pharmacology.  23 (2010)  3 - p. 951-954 , 2010
Link: https://doi.org/10.1177/..
 
?
7

The therapy of kidney cancer with biomolecular drugs:

Di Lorenzo, G. ; Buonerba, C. ; Biglietto, M....
Cancer Treatment Reviews.  36 (2010)  - p. S16-S20 , 2010
Link: https://doi.org/10.1016/..
 
?
8

The Clinical Impact of a Cardiologic Follow-up in Breast Ca..:

Gallucci, G. ; Coccaro, M. ; Storto, G....
International Journal of Immunopathology and Pharmacology.  23 (2010)  4 - p. 1221-1227 , 2010
Link: https://doi.org/10.1177/..
 
?
9

Liquid biopsy in bladder cancer: State of the art and futur..:

Crocetto F ; Barone B ; Ferro M...
info:eu-repo/semantics/altIdentifier/wos/WOS:000760149100003.  , 2022
Link: http://hdl.handle.net/11..
 
?
10

Increased Body Mass Index Is a Risk Factor for Poor Clinica..:

Ferro M ; Terracciano D ; Musi G...
info:eu-repo/semantics/altIdentifier/pmid/34167120.  , 2022
Link: http://hdl.handle.net/24..
 
?
11

COVID-19 and prostate cancer: A complex scenario with multi..:

Crocetto F ; Buonerba L ; Scafuri L...
info:eu-repo/semantics/altIdentifier/wos/WOS:000721508300001.  , 2022
Link: http://hdl.handle.net/11..
 
?
12

Neutrophil percentage-to-albumin ratio predicts mortality i..:

Ferro M ; Baba D. -F ; Cobelli O. D...
info:eu-repo/semantics/altIdentifier/pmid/34258022.  , 2021
Link: http://hdl.handle.net/11..
 
?
13

Kaempferol, myricetin and fisetin in prostate and bladder c..:

Crocetto F ; Di Zazzo E ; Buonerba C...
info:eu-repo/semantics/altIdentifier/wos/WOS:000726663600001.  , 2021
Link: http://hdl.handle.net/11..
 
?
14

Three vs. Four Cycles of Neoadjuvant Chemotherapy for Local..:

Ferro M ; de Cobelli O ; Musi G...
info:eu-repo/semantics/altIdentifier/pmid/34046347.  , 2021
Link: http://hdl.handle.net/24..
 
?
15

Does perioperative systemic therapy represent the optimal t..:

Scafuri L ; Sciarra A ; Crocetto F...
info:eu-repo/semantics/altIdentifier/pmid/34737893.  , 2021
Link: http://hdl.handle.net/11..
 
1-15